Perkins Diana O, Gu Hongbin, Boteva Kalina, Lieberman Jeffrey A
Department of Psychiatry, University of North Carolina School of Medicine, CB 7160, Chapel Hill, NC 27599, USA.
Am J Psychiatry. 2005 Oct;162(10):1785-804. doi: 10.1176/appi.ajp.162.10.1785.
The duration of untreated psychosis may influence response to treatment, reflecting a potentially malleable progressive pathological process. The authors reviewed the literature on the association of duration of untreated psychosis with symptom severity at first treatment contact and with treatment outcomes and conducted a meta-analysis examining these relationships.
English-language articles on duration of untreated psychosis published in peer-reviewed journals through July 2004 were reviewed. Studies that quantitatively assessed the duration of untreated psychosis; identified study subjects who met the criteria for nonaffective psychotic disorders at or close to first treatment; employed cross-sectional analyses of duration of untreated psychosis and of baseline symptoms, neurocognition, brain morphology, or functional measures or prospectively analyzed symptom change, response, or relapse; assessed psychopathology with clinician-rated instruments; and reported subjects' diagnoses (a total of 43 publications from 28 sites) were included in the meta-analysis.
Shorter duration of untreated psychosis was associated with greater response to antipsychotic treatment, as measured by severity of global psychopathology, positive symptoms, negative symptoms, and functional outcomes. At the time of treatment initiation, duration of initially untreated psychosis was associated with the severity of negative symptoms but not with the severity of positive symptoms, general psychopathology, or neurocognitive function.
Duration of untreated psychosis may be a potentially modifiable prognostic factor. Understanding the mechanism by which duration of untreated psychosis influences prognosis may lead to better understanding of the pathophysiology of schizophrenia and to improved treatment strategies.
未治疗精神病的持续时间可能会影响治疗反应,这反映了一个潜在的可塑的进行性病理过程。作者回顾了关于未治疗精神病持续时间与首次治疗接触时症状严重程度以及治疗结果之间关联的文献,并进行了一项荟萃分析来研究这些关系。
对截至2004年7月在同行评审期刊上发表的关于未治疗精神病持续时间的英文文章进行了回顾。纳入荟萃分析的研究需满足以下条件:定量评估未治疗精神病的持续时间;确定在首次治疗时或接近首次治疗时符合非情感性精神病障碍标准的研究对象;采用未治疗精神病持续时间与基线症状、神经认知、脑形态或功能指标的横断面分析,或前瞻性分析症状变化、反应或复发情况;使用临床医生评定工具评估精神病理学;并报告研究对象的诊断(共来自28个研究地点的43篇出版物)。
以总体精神病理学、阳性症状、阴性症状和功能结果的严重程度衡量,未治疗精神病持续时间较短与对抗精神病药物治疗的反应较大相关。在开始治疗时,最初未治疗精神病的持续时间与阴性症状的严重程度相关,但与阳性症状的严重程度、总体精神病理学或神经认知功能无关。
未治疗精神病的持续时间可能是一个潜在的可改变的预后因素。了解未治疗精神病持续时间影响预后的机制可能会增进对精神分裂症病理生理学的理解,并改善治疗策略。